Treatment Guidelines for Renal Calcifications

Evaluation and Diagnosis

Stone analysis is essential for determining composition and guiding preventive strategies 1
24-hour urine collection should be performed to evaluate metabolic abnormalities including volume, pH, calcium, oxalate, uric acid, citrate, sodium, potassium, and creatinine 1
Regular monitoring of serum calcium, phosphate, PTH, and alkaline phosphatase activity is recommended, especially in patients with CKD 2
Imaging studies help quantify stone burden and identify anatomical abnormalities 1

Increased fluid intake is the cornerstone of prevention for all stone types, targeting urine output of at least 2.5 liters daily 1
Dietary sodium restriction to less than 2,300 mg daily reduces urinary calcium excretion 1
Moderate calcium intake (800-1,200 mg/day) is recommended rather than restriction, as low calcium diets can paradoxically increase stone risk 1
Limiting non-dairy animal protein to 5-7 servings per week helps reduce stone formation 1

Thiazide diuretics should be offered to patients with high urine calcium and recurrent calcium stones 3, 4
Potassium citrate therapy is indicated for patients with recurrent calcium stones and low urinary citrate 3, 4
Allopurinol should be offered to patients with recurrent calcium oxalate stones who have hyperuricosuria and normal urinary calcium 3
Potassium citrate should be offered to raise urinary pH to approximately 6.0 for uric acid stones 3, 4
Potassium citrate should be offered to raise urinary pH to approximately 7.0 for cystine stones 3, 4
Increased fluid intake targeting at least 4 liters per day is crucial for cystine stones 1
Dietary sodium restriction should be advised as lower sodium intake reduces cystine excretion 4
Struvite stones occur as a consequence of urinary infection with urease-producing organisms 3
Complete surgical removal of the stone is often necessary for struvite stones 5
Prophylactic or suppressive antibiotic therapy should be considered for patients with struvite stones 5

In CKD patients, treatment approaches for mineral disorders should be based on serial assessments of phosphate, calcium, and PTH levels taken together 6, 2
Treatment should focus on patients with overt hyperphosphatemia rather than maintaining normal phosphate levels in non-dialysis patients 7, 2
Use of calcium-based phosphate binders should be restricted in patients with hyperphosphatemia 8, 7, 9
Hypercalcemia should be avoided in all GFR categories of CKD 7, 9

Obtain a 24-hour urine specimen within six months of initiating treatment to assess response to dietary and/or medical therapy 1
Regular monitoring of PTH, calcium, and phosphate levels is essential in CKD patients 2
Annual 24-hour urine collections should be scheduled to monitor treatment efficacy 1
Stone analysis should be repeated when new stones are available, especially if the patient is not responding to treatment 1

Inadequate fluid intake is the most common preventable cause of stone recurrence 1
Using sodium citrate instead of potassium citrate may increase urine calcium excretion and potentially worsen stone formation 3, 1
Prescribing calcium restriction without proper metabolic evaluation can increase stone risk 1
Overtreatment of secondary hyperparathyroidism can result in low bone turnover 9, 2
The interplay among biochemical variables (serum phosphate, calcium, and PTH) is complex, and therapeutic interventions aimed at improving one parameter often have unintended effects on others 6, 2

Thiazide diuretics combined with dietary sodium restriction effectively reduce hypercalciuria and stone recurrence 3, 4
Proper management of renal calcifications can prevent progressive kidney damage and preserve renal function 5